Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Journal of Neurological Sciences

• Publication date

  1977-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-510X(77)90073-9PMID 144789
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2-Dimethylaminoethanol (Deanol) in Huntington's chorea

  1978cited by this paper
• Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex.

  1977cited by this paper
• Human brain temperature at necropsy: a guide in post-mortem biochemistry.

  1977cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• HUMAN BRAIN TEMPERATURE AT NECROPSY: A GUIDE IN POST-MORTEM BIOCHEMISTRY

  1977cited by this paper
• ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA

  1976cited by this paper
• Some Cerebral Proteins and Enzyme Systems in Alzheimer's Presenile and Senile Dementia

  1976cited by this paper
• STABILITY OF ENZYMES IN POST‐MORTEM RAT BRAIN 1

  1976cited by this paper
• Biochemical indices of brain structure, function and "hypoxia" in cortex from baboons with middle cerebral artery occlusion.

  1976cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

  1976cited by this paper
• Aluminium, neurofibrillary degeneration and Alzheimer's disease.

  1976cited by this paper
• Distribution of glutamate decarboxylase in discrete brain nuclei.

  1976cited by this paper
• A rapid radiochemical method for the determination of choline acetyltransferase

  1975cited by this paper
• Glutamic acid decarboxylase, glutamine synthase and glutamic acid dehydrogenase in various areas of human brain.

  1975cited by this paper
• Chemical pathology of neurofibrils. Neurofibrillary tangles of Alzheimer's presenile-senile dementia.

  1975cited by this paper
• PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE

  1975cited by this paper
• DISTRIBUTION OF CHOLINE ACETYLTRANSFERASE AND GLUTAMATE DECARBOXYLASE WITHIN THE SUBSTANTIA NIGRA AND IN OTHER BRAIN REGIONS FROM CONTROL AND PARKINSONIAN PATIENTS

  1975cited by this paper
• GABA CONTENT AND GLUTAMIC ACID DECARBOXYLASE ACTIVITY IN BRAIN OF HUNTINGTON'S CHOREA PATIENTS AND CONTROL SUBJECTS 1

  1975cited by this paper
• Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.

  1974cited by this paper
• Post-mortem measurement of enzymes in human brain: evidence of a central noradrenergic deficit in schizophrenia.

  1974cited by this paper
• Brain-decarboxylase activities as indices of pathological change in senile dementia.

  1974cited by this paper
• Molecular changes in senile dementia.

  1973cited by this paper
• Effect of extracorporeal liver perfusion on the electroencephalogram of patients in coma due to acute liver failure.

  1973cited by this paper
• Cytosine arabinoside in herpes zoster.

  1973cited by this paper
• Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients.

  1973cited by this paper
• Granulovacuolar degeneration of hippocampal pyramidal cells

  1972cited by this paper
• Biochemistry of Middle and Late Life Dementias

  1972cited by this paper
• Studies in ageing of the brain. II. Microchemical analyses of the nervous system in Alzheimer patients.

  1972cited by this paper
• Glutamic acid decarboxylase in Parkinson's disease and epilepsy

  1971cited by this paper
• The Cholinergic Synapse and the Site of Memory

  1971cited by this paper
• Cholinergic enzyme systems in Parkinson's disease.

  1971cited by this paper
• Brain glutamate decarboxylase: changes in the developing rat brain 1

  1970cited by this paper
• ESTIMATION OF GLYCOLIPIDS IN FOUR SELECTED LOBES OF HUMAN BRAIN IN NEUROLOGICAL DISEASES 1

  1969cited by this paper
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

  1968cited by this paper
• Observations on the brains of demented old people.

  1968cited by this paper
• Observations on the brains of non-demented old people.

  1968cited by this paper
• The 'compartmentation' of choline acetyltransferase within the synaptosome.

  1967cited by this paper
• THE CONTRIBUTION OF ALTERED SYNAPSES IN THE SENILE PLAQUE: AN ELECTRON MICROSCOPIC STUDY IN ALZHEIMER'S DEMENTIA

  1967cited by this paper
• CHEMICAL STUDIES ON ALZHEIMER'S DISEASE

  1965cited by this paper
• Choline acetylase in the central nervous system of man and some other mammals

  1956cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Organization of the basal forebrain cholinergic system in the human brain.

  2025cites this paper
• Overactive Glutamatergic Basal Forebrain: Compensatory or Causal Mechanism in Cognitive Disorders.

  2025cites this paper
• CNEURO-201, an Anti-amyloidogenic Agent and σ1-Receptor Agonist, Improves Cognition in the 3xTg Mouse Model of Alzheimer’s Disease by Multiple Actions in the Pathology

  2025cites this paper
• Association between L-α glycerylphosphorylcholine use and delayed dementia conversion: A nationwide longitudinal study in South Korea

  2025cites this paper
• An appraisal on biomolecular imaging in diagnosis of neurological disorders and innovation in clinical research

  2025cites this paper
• Cognition and modulation of the cholinergic system.

  2025cites this paper
• Preclinical efficacy of the muscarinic agonist ML-007 in psychosis models depends on both M1 and M4 receptors.

  2025cites this paper
• Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer’s Disease

  2024cites this paper
• Neuroprotective Effect of Marrubium vulgare Extract in Scopolamine-Induced Cognitive Impairment in Rats: Behavioral and Biochemical Approaches

  2024cites this paper
• Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

  2024cites this paper
• Regulation of Hippocamposeptal Synaptic Transmission by GABABRs Is Altered in 5XFAD Mice in a Sex- and Age-Dependent Manner

  2024cites this paper
• The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease

  2024cites this paper
• Investigating the disease‐modifying properties of sclerotiorin in Alzheimer's therapy using acetylcholinesterase inhibition

  2023cites this paper
• Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?

  2023cites this paper
• Radiosynthesis and whole‐body distribution in mice of a 18F‐labeled azepino[4,3‐b]indole‐1‐one derivative with multimodal activity for the treatment of Alzheimer's disease

  2023cites this paper
• Exploring the efficient natural products for Alzheimer’s disease therapy via Drosophila melanogaster (fruit fly) models

  2023cites this paper
• Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.

  2023cites this paper
• Kisspeptin-10 Mitigates α-Synuclein-Mediated Mitochondrial Apoptosis in SH-SY5Y-Derived Neurons via a Kisspeptin Receptor-Independent Manner

  2023cites this paper
• The role of astrocytic α7 nicotinic acetylcholine receptors in Alzheimer disease

  2023cites this paper
• Discoveries and future significance of research into amyloid-beta/α7-containing nicotinic acetylcholine receptor (nAChR) interactions

  2023cites this paper
• Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome

  2023cites this paper
• Astrocyte energy and neurotransmitter metabolism in Alzheimer's disease: integration of the glutamate/GABA-glutamine cycle.

  2022cites this paper
• Population pharmacokinetic modeling and simulation of choline in healthy Korean subjects after oral administration of choline alfoscerate

  2022cites this paper
• Sesamol Attenuates Scopolamine-Induced Cholinergic Disorders, Neuroinflammation, and Cognitive Deficits in Mice.

  2022cites this paper
• Early loss of locus coeruleus innervation promotes cognitive and neuropathological changes before amyloid plaque deposition in a transgenic rat model of Alzheimer's disease

  2022cites this paper
• A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics

  2022cites this paper
• Alternative Pharmacological Strategies for the Treatment of Alzheimer’s Disease: Focus on Neuromodulator Function

  2022cites this paper
• Synthesis, characterizations of aryl-substituted dithiodibenzothioate derivatives, and investigating their anti-Alzheimer's properties

  2022cites this paper
• Evaluation of galantamine and deconstructed analogs as α7 nAChR and AChE ligands

  2022cites this paper
• A History of Senile Plaques: From Alzheimer to Amyloid Imaging.

  2022cites this paper
• Marine Natural Products from the Russian Pacific as Sources of Drugs for Neurodegenerative Diseases

  2022cites this paper
• Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer’s Disease, Parkinson’s Disease, or Frontotemporal Dementia: Implications for Patient Survival

  2022cites this paper
• A tough trek in the development of an anti-amyloid therapy for Alzheimer's disease: Do we see hope in the distance?

  2022cites this paper
• Altered Neurotransmitter Ratio in the Prefrontal Cortex is Associated with Pain in Fibromyalgia Syndrome

  2021cites this paper
• Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance

  2021cites this paper
• Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer’s Disease

  2021cites this paper
• Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies

  2021cites this paper
• The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders

  2021cites this paper
• Prescribing cholinesterase inhibitors in mild cognitive impairment—Observations from the Alzheimer's Disease Neuroimaging Initiative

  2021cites this paper
• Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges

  2020cites this paper
• Therapeutic Potential of Multifunctional Derivatives of Cholinesterase Inhibitors

  2020cites this paper
• How Arousal-Related Neurotransmitter Systems Compensate for Age-Related Decline

  2020cites this paper
• A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy

  2020cites this paper
• Tau phosphorylation by glycogen synthase kinase 3β modulates enzyme acetylcholinesterase expression

  2020cites this paper
• Çuha Çiçeği (Oenothera biennis) ve Tatlı Badem (Prunus dulcis Mill) Yağlarının Anti-enzim Aktivitelerinin Araştırılması

  2020cites this paper
• Use of 192 IgG-saporin as a model of dementia and its application

  2020cites this paper
• Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders

  2020cites this paper
• Regulatory Objectivity in Action: Mild Cognitive Impairment and the Collective Production of Uncertainty

  2020cites this paper
• Scopolamine, a toxin-induced experimental model used for research in Alzheimer's disease.

  2020cites this paper
• The antioxidant 2,3‐dichloro,5,8‐dihydroxy,1,4‐naphthoquinone inhibits acetyl‐cholinesterase activity and amyloid β42 aggregation: A dual target therapeutic candidate compound for the treatment of Alzheimer's disease

  2019cites this paper
• Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia

  2019cites this paper
• Dementia spectrum disorders: lessons learnt from decades with PET research

  2019cites this paper
• Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review.

  2019cites this paper
• The Nucleus Basalis of Meynert and Its Role in Deep Brain Stimulation for Cognitive Disorders: A Historical Perspective

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Altered GABAergic Function, Cortical Microcircuitry, and Information Processing in Depression

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Multidisciplinary approaches for targeting the secretase protein family as a therapeutic route for Alzheimer's disease

  2019cites this paper
• Elaeagnus glabra f. oxyphylla Attenuates Scopolamine-Induced Learning and Memory Impairments in Mice by Improving Cholinergic Transmission via Activation of CREB/NGF Signaling

  2019cites this paper
• Blood acetylcholinesterase level is a potential biomarker for the early detection of cerebral amyloid deposition in cognitively normal individuals.

  2019cites this paper
• Potential Enzymatic Targets in Alzheimer's: A Comprehensive Review.

  2019cites this paper
• THE IMPACT OF NEONATAL ALCOHOL EXPOSURE AND VOLUNTARY EXERCISE ON CHOLINERGIC FIBER LENGTH AND CG2 VOLUME IN THE RAT MEDIAL PREFRONTAL CORTEX

  2019cites this paper
• Acetylcholine

  2019cites this paper
• Identification d'un profil de marqueurs périphériques lié aux scores cognitifs dans le plasma et les vésicules extracellulaires durant le développement de la maladie d'Alzheimer: évolution de marqueurs liés au stress oxydatif et aux mécanismes physiopathologiques.

  2019cites this paper
• Modelling the neurobiology of Alzheimer’s disease in vitro

  2019cites this paper
• Augmentation of Endogenous Acetylcholine Uptake and Cholinergic Facilitation of Hippocampal Long-Term Potentiation by Acetylcholinesterase Inhibition.

  2019cites this paper
• Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).

  2019cites this paper
• Compensate for Age-Related Decline

  2019cites this paper
• The GABAergic system as a therapeutic target for Alzheimer's disease

  2018cites this paper
• Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.

  2018cites this paper
• Progress of Essential Oils in Prevention and Treatment of Alzheimer’s Disease

  2018cites this paper
• Distribution of choline acetyltransferase (ChAT) immunoreactivity in the brain of the teleost Cyprinus carpio

  2018cites this paper
• TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects

  2018cites this paper
• A novel liquid chromatography/mass spectrometry method for determination of neurotransmitters in brain tissue: Application to human tauopathies.

  2018cites this paper
• Neurochemical markers as potential indicators of postmortem tissue quality.

  2018cites this paper
• Major or Mild Vascular Neurocognitive Disorder

  2018cites this paper
• The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.

  2018cites this paper
• Design, synthesis and evaluation of indole derivatives as multifunctional agents against Alzheimer's disease.

  2018cites this paper
• Novel Modifiers of Aβ42 Toxicity in Drosophila

  2018cites this paper
• Izraženost biljega Iba1, CD68 i HLA-DR aktiviranih mikroglija stanica u hipokampalnoj formaciji osoba oboljelih od Alzheimerove bolesti

  2018cites this paper
• Assessing Cognition In A Mouse Model Of Alzheimer’s Disease

  2018cites this paper
• CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2N141I neurons

  2017cites this paper
• Cholinergic modulation of the hippocampal region and memory function

  2017cites this paper
• Novel dehydroabietylamine derivatives as potent inhibitors of acetylcholinesterase.

  2017cites this paper
• White matter lesions and the cholinergic deficit in aging and mild cognitive impairment.

  2017cites this paper
• N-Phenacylthiazolium Salts as Inhibitors of Cholinesterases

  2017cites this paper
• Animal models for studying motor axon terminal paralysis and recovery

  2017cites this paper
• Increase in cortical endocannabinoid signaling in a rat model of basal forebrain cholinergic dysfunction.

  2017cites this paper
• Recent findings on nonpharmacological therapies in Alzheimer ’ s Disease : New hope for patients ?

  2017cites this paper
• Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression

  2017cites this paper
• Is the Association Between Education and Cognitive Resilience Modified by Brain Weight and Cortical Atrophy

  2017cites this paper
• CHARLES UNIVERSITY IN PRAGUE

  2017cites this paper
• Multi-target-directed therapeutic potential of 7-methoxytacrine-adamantylamine heterodimers in the Alzheimer's disease treatment.

  2017cites this paper
• Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression

  2017cites this paper
• Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease.

  2017cites this paper
• Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.

  2016cites this paper
• Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder

  2016cites this paper
• Neurodegenerative and Vascular Involvement in Post Stroke Dementia

  2016cites this paper
• Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease

  2016cites this paper
• Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer’s disease Neurons

  2016cites this paper